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Abstract
Neuroscience has come to mean the study of electrophysiology of neurons and synapses, micro 
and macro-scale neuroanatomy, and the functional organization of brain areas. The molecular axis 
of the field, as reflected in textbooks, often includes only descriptions of the structure and function 
of individual channels and receptor proteins, and the extracellular signals that guide development 
and repair. Studies of cytosolic “molecular machines”, large assemblies of proteins that orchestrate 
regulation of neuronal functions, have been neglected. However, a complete understanding of 
brain function that will enable new strategies for treatment of the most intractable neural disorders 
will require that in vitro biochemical studies of molecular machines be reintegrated into the field 
of neuroscience.
Bruce Alberts and others introduced the concept of “molecular machines” about two 
decades ago to describe large assemblies of biomolecules that are specialized to perform 
particular cellular functions [1]. Much of modern cell biology involves the study of such 
molecular machines. The goal is to understand how they execute and coordinate the 
multitude of cell functions required for life. Active areas of study include the intricate 
structures that form transcriptional complexes [2], the nuclear pores that control movement 
of macromolecules between nucleus and cytoplasm [3], transient vesicle structures that 
transport molecular machines to distal parts of the cell [4], and the emerging study of 
membrane-less compartments, such as the nucleolus [5*]. Neurons contain unique molecular 
machines, but their study has often lagged behind those that are common to most cell types.
The word “synapse” used to be defined as the gap between the presynaptic terminal and the 
postsynaptic site. However, for those of us who study synaptic function, the word has come 
to mean the combination of the presynaptic bouton where transmitter is released, the 
synaptic cleft, and the plaque of postsynaptic neurotransmitter receptors and associated 
protein structures that regulate their assembly. Excitatory synapses in the mammalian brain 
comprise a particularly large, complicated set of protein machines specialized to process 
information about the environment in real time and then store it by adjusting the strengths of 
synapses that connect neurons when they are activated together by an environmental event.
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Mechanisms of transmitter release by exocytosis from synaptic vesicles are closely related to 
fundamental mechanisms of exocytosis in many cells [e.g. 6]. As a result, synaptic vesicles 
isolated from the brain have often served as a convenient and abundant source of 
biochemical material to study the exocytotic machinery. Biochemical studies of individual 
purified vesicle proteins, structural studies at the electron microscopic and atomic level, and 
sophisticated microphysiological measurements with electrodes have all contributed to our 
present understanding of the interactions of vesicle proteins with the “SNARE” machinery 
that ultimately brings about release of neurotransmitter into the synaptic cleft [7**].
In contrast, study of molecular mechanisms in the postsynaptic spines of excitatory synapses 
has been more fraught. Just one year after Alberts published his article on molecular 
machines in the cell, Sanes and Lichtman published a review in Nature Neuroscience with 
the improbable title, “Can Molecules Explain LTP?” [8]. To understand the gulf between the 
emerging biochemistry of the cell at the turn of the century, and the molecular sophistication 
of the neuroscience field, simply imagine the response if a prominent cell biologist had 
published a review entitled, “Can molecules explain the cell cycle?” or “Can molecules 
explain gene expression?”. In 1998, the notion that molecular explanations of complex 
cellular functions were in sight had permeated the field of cell biology. In contrast, 
neuroscientists, most of whom are trained fundamentally in electrophysiology or biophysics, 
were all too ready to give up, for the time being, on molecular explanations of neuronal 
function.
Unfortunately, cell biologists don’t generally view the molecular machinery that forms and 
remodels the postsynaptic plaque of receptors in spines as representative of universal cellular 
processes. They have generally viewed these neuronal structures as more complex and 
heterogenous than machinery that regulates receptors in other tissues and thus less amenable 
to biochemical study. This situation is reflected in the composition of textbooks covering 
cell biology. Many of them mention synaptic vesicle proteins when discussing exocytosis. 
However, chapters on integrated intercellular signaling use the immune system as an 
example, and avoid the complexities of postsynaptic signaling [e.g. 9]. Conversely, 
neuroscience textbooks generally cover molecular mechanisms with simplified cartoons [e.g. 
10,11].
A relatively small cohort of intrepid researchers, usually located in molecular neuroscience 
laboratories, have tackled the molecular mechanisms of formation and pruning of synapses, 
and the modulatory mechanisms that tune the strengths of synapses (“synaptic plasticity”). 
Through their efforts, usually carried out in isolation from laboratories focused on cell 
biology and biochemistry, most of the key individual proteins involved in postsynaptic 
signaling and modulation have been identified. However, our understanding of how these 
proteins work together to provide the subtle, yet vital tuning of synaptic machinery 
necessary to support stable brain functions lags behind, and is difficult to fund. A deep 
understanding of the properties and behavior of individual proteins and their interactions as 
they assemble into protein machinery is as crucial for a full understanding of neuroscience 
as it is for all branches of cell biology. In this review, I will discuss two examples from the 
recent literature of what I believe to be oversimplified interpretation of studies of synaptic 
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plasticity in living neuronal preparations, and the deeper understanding that arises from 
taking into account the biochemical properties of individual proteins.
The role of PKMζ in maintenance of late-phase LTP
It has been customary to divide mechanisms of long term potentiation of excitatory synapses 
(LTP) into two broad phases (see Fig. 1C). The induction phase refers to the period during 
which synaptic activity initiates biochemical changes that ultimately result in stable 
potentiation, and is usually considered to include the first 10 to 20 minutes after an inducing 
stimulus. The maintenance phase refers to the period after induction during which the 
synapse has reached a new level of strength that persists for an indefinite period. It is usually 
considered to begin ~20 minutes after the inducing stimulus. The term “late-LTP” refers to 
the period from ~1 hour to as long as an experiment lasts, which for experiments carried out 
on hippocampal slices, can be up to 9 hours.
A great deal of attention has been focussed on the mechanisms of induction. We know that 
the ultimate strength of potentiation and its endurance depend on the nature of the inducing 
stimulus. Thus investigators have sought to explain how various synaptic stimuli alter 
synaptic biochemistry in the few minutes after the stimulus. At this time, all agree that the 
critical early event is activation of NMDA-type glutamate receptors that gate a large flux of 
Ca2+ into the postsynaptic cytosol [12]. It is also agreed that activation of phosphorylation 
events by the abundant postsynaptic protein kinase, Ca2+/calmodulin-dependent protein 
kinase II (CaMKII) initiates a cascade of biochemical changes that ultimately remodel the 
synapse to contain more AMPA-type glutamate receptors and larger pre- and postsynaptic 
specializations [13]. What is less clear, and more controversial, are the precise biochemical 
changes that cause a potentiated synapse to maintain its increased strength essentially 
indefinitely, an indurance that is necessary for formation of long-lasting memory [14].
Recently, a major clue about the mechanisms of maintenance of LTP fell firmly into place: 
Increased synthesis of one particular stable isoform of the atypical protein kinase Cζ 
(PKCζ), termed PKMζ, is necessary for fully maintained LTP, and can stably increase 
synaptic strength when its concentration is increased in a postsynaptic spine.
The first work leading to this now well established conclusion was presented in a series of 
carefully executed and beautifully written papers by Todd Sacktor’s lab from 1993 to 2004. 
It began with a paper in which they showed that a constitutively active fragment of PKCζ, 
referred to as PKMζ, is upregulated in hippocampal slices during the maintenance phase of 
LTP [15]. At that time, PKMζ was thought to be generated by proteolysis of PKCζ by the 
Ca2+-dependent protease calpain. However, the Sacktor lab soon found that the increased 
formation of PKMζ following induction of LTP was dependent on protein synthesis [16], 
and that, contrary to previous assumptions, PKMζ is a true alternative gene product of the 
PKCζ gene [17]. The mRNA encoding PKMζ is transcribed from an alternative promoter of 
the gene, and PKMζ is translated de novo from that mRNA. The PKMζ mRNA is rapidly 
transported from the nucleus into dendrites [18] and PKMζ is the major form of the kinase 
expressed from the PKCζ gene in hippocampus and neocortex [17]. Much of this 
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foundational work involved traditional biochemical experiments carried out in the Sacktor 
lab.
To examine the role of PKMζ in maintenance of LTP and the persistence of memory, the 
Sacktor lab used a known pharmacological inhibitor of PKMζ, chelerythrine, and developed 
a second, myristoylated ζ-pseudosubstrate (later named ZIP) based on the sequence of the 
inhibitory domain of PKCζ. A key set of electrophysiological experiments [19] 
demonstrated that specific inhibition of PKMζ one hour after induction of LTP in 
hippocampal slices by either chelerythrine or the ZIP inhibitor reversed LTP. Furthermore, 
introduction of recombinantly expressed PKMζ into a pyramidal neuron through a patch 
electrode increased the evoked excitatory postsynaptic currents as much as 100% in 10 min. 
This set of experiments appeared to establish the unique importance of PKMζ for 
maintaining the later phases of LTP. Several studies have since shown that introduction of 
ZIP peptide by infusion into various regions of the mouse brain can reverse learning of 
several behaviors as long as 3 months after the learning occurred [20].
Nonetheless, a fly appeared in the ointment in 2013 in the form of two papers published in 
the journal “Nature” showing that mice with targeted deletion of the PKCζ gene, a mutation 
that also eliminates expression of PKMζ, showed normal synaptic plasticity in the 
hippocampus [21] and normal long-term learning of several behavioral tasks [22]. 
Furthermore, the ZIP peptide inhibited LTP and could reverse memory of learned tasks when 
infused into the brains of trained mutant mice missing PKMζ. These surprising experiments 
seemed to indicate that another, as yet unknown, protein, also inhibited by ZIP, was the true 
mediator of maintenance of LTP and memory formation. One of the papers [21] mentioned 
the possibility that an atypical PKC that is closely related to PKMζ, PKCλ/ι, might also be 
inhibited by ZIP and might be “compensating” for PKMζ. However, the investigators cast 
doubt on this possibility after failing to find increased expression of PKCλ/ι two hours after 
induction of LTP in the mutant mice.
Drawing upon their deep understanding of the biochemistry of atypical PKC’s, the Sacktor 
group next devised a series of carefully controlled experiments [23**] that established the 
following key facts: 1. PKCλ/ι is indeed inhibited by ZIP, although at a slightly higher 
concentration of ZIP than required for inhibition of PKMζ; 2. Transient knockdown of 
PKMζ with antisense RNA inhibits maintenance of LTP in hippocampal slices from wild 
type mice, but does not inhibit it in slices from PKMζ null mice; 3. The amount of PKCλ/ι 
is transiently increased after tetanization of slices from wild type mice, but the increase 
becomes persistent in PKMζ null mice and lasts for at least 3 hours after the tetanus (Fig. 
1A); 4. A newly established specific inhibitor of PKCλ/ι, termed ICAP [24,25], reverses 
late-LTP maintenance in PKMζ null mice, but not in wild type mice (Fig. 1B, C); and 5. 
Similar differences between wild type and PKMζ null mice are found for inhibition of 
behavioral learning.
In addition to re-establishing that PKMζ is indeed a primary regulator of maintenance of 
late-LTP in wild type mice [26*], these experiments uncovered a subtle redundancy in the 
maintenance mechanism. In wild type animals, new synthesis of PKMζ after LTP-inducing 
stimuli produces a down-regulation of the synthesis of PKCλ/ι. However, when PKMζ is 
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deleted, the down-regulation doesn’t occur and PKCλ/ι remains elevated for a longer 
period. The Sacktor group went on to show that the compensation by PKCλ/ι in PKMζ null 
mice isn’t perfect [23], as might be expected from the principles of evolution. When given 
increasingly demanding cognitive tests, the PKMζ null mice began to perform measurably 
less well than wild type mice.
In this example, deep knowledge of the biochemical characteristics of the enzymes being 
studied (PKMζ and PKCλ/ι), and the mechanisms by which they are regulated, was 
necessary to fully unravel the primary importance of PKMζ in the wild type and the subtly 
intertwined roles of the two enzymes in maintenance of LTP and memory. Without it, the 
two genetic studies that found PKMζ to be unnecessary for maintenance of late LTP might 
have stood as the last word and the field would have been set back.
The role of synGAP in induction of LTP
Many electrophysiologists say that the immediate results and instant interaction with a 
neuronal preparation that occurs during their experiments is the genesis of their passion for 
neuroscience. Perhaps for this reason, neuroscience students are often taught that “real time” 
imaging of heterologously expressed fluorescent proteins in vivo coupled with 
electrophysiology (sometimes called “molecular replacement experiments”) is the gold 
standard for mechanistic studies. The erroneous notion that these methods are “more 
physiological” than studies of purified proteins ignores the disruption of intracellular 
biochemistry that is created by over-expression (or under-expression) of fluorescently 
labeled heterologous proteins in cells. Principles of physical biochemistry tell us that both 
the timing (kinetics) and the binding affinities that normally govern interactions between 
intracellular molecules are altered by over- and under-expression, as well as by modification 
of proteins with hydrophobic fluorescent moieties. When appropriately controlled, these 
methods are certainly useful to test ideas about the behavior of well-understood individual 
proteins in vivo, but the introduction of altered molecules always perturbs the system. 
Therefore, these methods are not adequate by themselves to unravel complex molecular 
mechanisms or reveal the fine-tuned workings of synaptic molecular machinery. An accurate 
interpretation of such experiments requires an understanding of the intrinsic properties of the 
proteins, including enzymatic rates and binding constants. These properties can only be 
adequately understood by studying purified proteins in vitro.
I illustrate this assertion with recent studies of the roles of the protein synGAP in the early 
stages of induction of LTP. SynGAP is an abundant cytosolic regulatory enzyme that 
localizes specifically to the postsynaptic spine and nearby dendrite. It binds to the scaffold 
structure underlying the postsynaptic membrane, known as the postsynaptic density (PSD) 
[13]. SynGAP contains a Ras GTPase activating domain that interacts with activated Ras 
protein to accelerate the rate of hydrolysis of its bound GTP molecule, which inactivates Ras 
[27,28]. A C2 domain adjacent to the RasGAP domain confers additional specificity for 
acceleration of inactivation of Rap [29]. SynGAP is held near the postsynaptic membrane, in 
part, because one of its alternatively spliced variants, termed synGAP-α1, has a PDZ 
domain ligand that binds to the PDZ domains of PSD-95 [see 30]. PSD-95 is a major PSD 
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scaffold protein and binds many postsynaptic receptors and signaling proteins via its three 
PDZ domains [13].
Two recent imaging studies showed that activation of Ca2+/calmodulin-dependent protein 
kinase II (CaMKII) by synaptic NMDA-type glutamate receptors (NMDARs) causes 
synGAP to move away from the core of the PSD. One study (Fig. 2) showed by electron 
microscopy that two major isoforms of synGAP, synGAP-α1, which contains the PDZ 
ligand, and synGAP-α2 which does not, move away from the synaptic membrane after 
phosphorylation and appear to associate with a cloud of material that underlies and 
surrounds the PSD proper [31]. A second study showed that fluorescent synGAP-α1, 
introduced into neurons by “molecular replacement”, disperses away from the synaptic 
junction when NMDARs on individual spines are activated by “chemLTP” [32*]. It appears 
to move into the adjacent shaft where it is diluted. Araki et al. [32] theorized that the 
dispersal of syn-GAP removes a negative influence on the activation of Ras at the synapse. 
Indeed, they used a fluorescent FRET indicator to show, as have others [33], that the amount 
of active Ras in a spine increases upon activation of NMDARs and subsequent movement of 
syn-GAP out of the spine. They concluded that movement of synGAP away from the PSD 
facilitates activation of Ras, which is necessary for increases in spine size and addition of 
new AMPA-type glutamate receptors (AMPARs) to the spine membrane [32].
In contrast, two recent biochemical studies from my lab indicate that the mechanism 
underlying addition of new AMPARs is both more subtle and more complex than proposed 
by Araki et al. It has been known for some time that SynGAP accelerates inactivation of Rap 
as well as Ras [29,34]. Thus, movement of synGAP out of the spine would be expected to 
activate Rap, as well as Ras. Expression of active Rap in neurons accelerates endocytosis of 
AMPARs; whereas, expression of active Ras has the opposite effect, accelerating exocytosis 
of AMPARs [35]. The fold stimulation of Rap inactivation by synGAP is considerably 
higher than its stimulation of inactivation of Ras [36*]. This means that simple loss of syn-
GAP from the spine would be expected to cause a greater increase in active Rap in the spine 
and a loss of surface AMPARs, in contrast to the model proposed by Araki et al.. Indeed, we 
found that phosphorylation of synGAP by CaMKII doubles the rate of synGAP’s 
inactivation of Rap [36]. Thus, one of the same phosphorylation events that promotes 
detachment of synGAP from the PSD, also causes its rate of inactivation of Rap to increase, 
not decrease. This would result in a rapid reduction of active Rap, and a concomitant 
reduction of endocytosis, along the peripheral spine and dendritic membrane, as synGAP 
disperses away from the PSD. Our results suggest that, rather than eliminating the effect of 
synGAP on Ras and Rap activity, the rheostat-like shifting of the enzymatic specificity of 
synGAP by phosphorylation would shift the balance toward exocytosis of receptor at the 
extrasynaptic membrane, as synGAP moves away from the PSD. Interestingly, 
phosphorylation of another site on synGAP by the homeostatic enzyme Cdk5, increases the 
rate of inactivation of Ras, without altering the rate of inactivation of Rap, turning the 
rheostat in the opposite direction, presumably leading to reduction of the number of surface 
receptors [36].
In a second biochemical study, we uncovered a function of synGAP unrelated to its GAP 
activity [37**]. We found that phosphorylation of synGAP by CaMKII at several sites 
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progressively reduces the affinity of synGAP binding to all three PDZ domains of PSD-95. 
This effect involves phosphorylation of more sites than identified in [32] and has more 
consequences than simple movement of synGAP out of the PSD. Because synGAP is 
remarkably abundant in the PSD, nearly as abundant as PSD-95 itself, we theorized that it 
might serve as a placeholder to regulate the number of PDZ domain “slots” on the scaffold 
available for binding AMPARs or other proteins. To test this idea, we measured the relative 
abundance of several PSD proteins in isolated PSD fractions from mouse brains, 
normalizing all of the measurements to the corresponding amounts of PSD-95. We 
compared the abundance of proteins in PSDs from wild type mice to those from mice with a 
deletion of one copy of the synGAP gene, which halves the amount of synGAP in the brain 
[38]. As expected, mice with the synGAP deletion have less synGAP per PSD-95 molecule 
(Fig. 3A). Somewhat to our surprise, the experiment also revealed that PSDs from mice with 
the synGAP deletion have a significantly larger amount of AMPA receptor chaperone 
proteins (TARPs [39] and LRRTMs [40]) that help anchor AMPA receptors into the PSD by 
binding them to PSD-95 (Fig. 3B,C). This result supports the hypothesis that synGAP acts 
as a placeholder by occupying PDZ domains “slots” on PSD-95. The effects of 
phosphorylation on affinity of synGAP for PDZ domains of PSD-95 further suggest that the 
placeholder function is regulated by activation of NMDARs [37].
Conclusion
Unfortunately, the relatively blunt tools of electrophysiology and imaging favored by 
neuroscientists do not have the resolution to parse individual biochemical steps in synaptic 
formation or plasticity. On the other hand, because this machinery is both complex and 
embedded in the heterogenous brain “neuropil”, it is tricky to study by standard cell 
biological and biochemical methods. The erroneous notion that in vivo imaging of 
fluorescent proteins is “more physiological” than biochemical studies of purified proteins, 
and the inherent difficulty of isolating postsynaptic neuronal preparations from the brain 
may have discouraged investigators trained in cell biology from turning their attention to 
neurons and synapses. It is increasingly clear, however, that many of the most intractable 
mental disorders, including schizophrenia, autism, and intellectual disability, involve 
dysfunction of synaptic regulatory machinery. To make progress in treating these disorders, 
neuroscientists need to begin accepting, valuing, and funding quantitative, in vitro, 
biochemical studies of proteins in addition to “real-time” imaging experiments.
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Highlights
• All cells contain many “molecular machines” that carry out complex cellular 
functions.
• Neuroscience has lagged behind in the study of specialized neuronal 
molecular machines.
• Insight into neuronal molecular mechanisms depends on deep biochemical 
knowledge.
• That insight will require renewed interest in studies of specialized neuronal 
proteins in vitro.
• Understanding of intractable mental disorders will also require in vitro 
biochemical studies.
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Figure 1. 
In PKMζ null mutant mice, PKCι/λ compensates for the normal function of PKMζ. A) In 
Wild-type mice, tetanization increases the amount of PKMζ at 3 hrs after stimulus, but does 
not increase the amount or phosphorylation of PKCι/λ. In PKMζ null mice, tetanization 
increases the amount of PKCι/λ and its phosphorylated form. B) Maintenance of late phase 
LTP in hippocampal slices from PKMζ null mice (filled circles) is reversed by application of 
the PKCι/λ antagonist, ICAP (10 μM) when it is applied 3 hrs post tetanus. Tetanus was 
applied at the time indicated by the arrow. The inset shows representative extracellular 
recorded EPSPs (field Excitatory PostSynaptic Potentials) at the time points indicated by 
small numbers. C) ICAP has no effect on maintenance of late LTP in wild type hippocampal 
slices (filled circles). As expected, inhibition of PKCι/λ by ICAP blocks induction of LTP 
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in a second pathway in the same wild type slice (open circles). This control shows that the 
inhibitor is working. The inset on the right is an additional control showing that, in the 
absence of ICAP, LTP can be induced in a second pathway by tetanization after 270 min of 
incubation of the slice. Reproduced from Tsokas et al. eLife 2016;5:e14846. DOI: 10.7554/
eLife.14846 [23]
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Figure 2. 
Activation of CaMKII by NMDA receptors causes synGAPα1 and synGAPα2 to move 
away from the postsynaptic membrane. SynGAP moves into the periphery of the PSD, 
which the authors refer to as the “pallium.” Hippocampal cultures were fixed and stained by 
immunogold-labeling for the isoform of synGAP that contains a PDZ ligand (α1) and the 
isoform that does not (α2). A) Control labeling; B) Cultures were incubated with tatCN21, 
an inhibitor of CaMKII; C) Cultures were exposed to 50 μM NMDA for 2 min; D) Cultures 
were treated with NMDA and a control, scrambled peptide that does not inhibit CaMKII 
(tatCtrl); E) Cultures were treated with NMDA and tatCN21. Reproduced from Yang et al. 
(2013) PLoS ONE 8(8): e71795. doi:10.1371/journal.pone.0071795 [31].
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Figure 3. 
Altered composition of the postsynaptic density in mice with heterozygous deletion of 
synGAP. In these experiments, postsynaptic densities were prepared by standard procedures 
from pooled brains of six synGAP heterozygous (HET) mice and six wild type (WT) litter 
mates. The ratios of amounts of each protein to the amount of PSD-95 in the two 
postsynaptic density preparations were determined from quantitative immunoblots scanned 
with a Li-Cor Odyssey scanner. Individual points (n) are technical replicates of the ratios 
determined from single lanes on sets of gels each containing six lanes of 5 μg wild type PSD 
and six lanes of 5μg synGAP HET PSD. A) Ratios of synGAP to PSD-95 in WT and HET. p 
= 0.0007; Cohen’s d (effect size) = 1.75. B) Ratios of TARPs to PSD-95 in WT and HET. p 
= 0.017, Cohen’s d = 0.93. C) Ratios of LRRTM2 to PSD-95 in WT and HET. p = 0.0035, 
Cohen’s d = 0.66. Reproduced from Walkup et al. eLife 2016;5:e16813. DOI: 10.7554/
eLife.16813 [37].
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